Cargando…
The 31-nucleotide Y4-RNA fragment in plasma is a potential novel biomarker
The 31- and 32-nt 5′-fragment of Y4-RNA (Y4RNAfr) exists abundantly in human peripheral blood plasma. Although physiological roles of the plasma Y4RNAfr are not well established, its potential utility as a diagnostic/prognostic marker for acute coronary syndrome was suggested. In this paper, to esta...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
KeAi Publishing
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7078377/ https://www.ncbi.nlm.nih.gov/pubmed/32206739 http://dx.doi.org/10.1016/j.ncrna.2019.12.001 |
_version_ | 1783507609256460288 |
---|---|
author | Ishikawa, Tatsuya Haino, Arisa Seki, Mineaki Kurihara, Taro Hirose, Takayuki Imai, Yosuke Ishiguro, Takuro Chou, Takaaki Toshima, Muneatsu Terada, Hiroshi Nashimoto, Masayuki |
author_facet | Ishikawa, Tatsuya Haino, Arisa Seki, Mineaki Kurihara, Taro Hirose, Takayuki Imai, Yosuke Ishiguro, Takuro Chou, Takaaki Toshima, Muneatsu Terada, Hiroshi Nashimoto, Masayuki |
author_sort | Ishikawa, Tatsuya |
collection | PubMed |
description | The 31- and 32-nt 5′-fragment of Y4-RNA (Y4RNAfr) exists abundantly in human peripheral blood plasma. Although physiological roles of the plasma Y4RNAfr are not well established, its potential utility as a diagnostic/prognostic marker for acute coronary syndrome was suggested. In this paper, to establish a normal range of the Y4RNAfr level in plasma, we measured plasma Y4RNAfr levels of 40 healthy persons using the method we have developed, and compared them with other blood test data. From the obtained data, we tentatively regarded <0.1 fmol/ng as normal for the Y4RNAfr level in peripheral blood plasma. And the white blood cell count (WBC) and the C-reactive protein (CRP) level showed moderate positive correlations with the Y4RNAfr level, suggesting that Y4RNAfr could be a potential novel inflammatory marker. We also measured the Y4RNAfr level in peripheral blood plasma from four multiple myeloma patients. The plasma Y4RNAfr level was abnormal in all four myeloma patients, and the levels for two patients were far beyond the normal level. The WBC for each patient was normal and the CRP levels for two patients were normal. These observations together suggest that a high level of Y4RNAfr in peripheral blood plasma and a normal WBC could be indicative of multiple myeloma. |
format | Online Article Text |
id | pubmed-7078377 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | KeAi Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-70783772020-03-23 The 31-nucleotide Y4-RNA fragment in plasma is a potential novel biomarker Ishikawa, Tatsuya Haino, Arisa Seki, Mineaki Kurihara, Taro Hirose, Takayuki Imai, Yosuke Ishiguro, Takuro Chou, Takaaki Toshima, Muneatsu Terada, Hiroshi Nashimoto, Masayuki Noncoding RNA Res Article The 31- and 32-nt 5′-fragment of Y4-RNA (Y4RNAfr) exists abundantly in human peripheral blood plasma. Although physiological roles of the plasma Y4RNAfr are not well established, its potential utility as a diagnostic/prognostic marker for acute coronary syndrome was suggested. In this paper, to establish a normal range of the Y4RNAfr level in plasma, we measured plasma Y4RNAfr levels of 40 healthy persons using the method we have developed, and compared them with other blood test data. From the obtained data, we tentatively regarded <0.1 fmol/ng as normal for the Y4RNAfr level in peripheral blood plasma. And the white blood cell count (WBC) and the C-reactive protein (CRP) level showed moderate positive correlations with the Y4RNAfr level, suggesting that Y4RNAfr could be a potential novel inflammatory marker. We also measured the Y4RNAfr level in peripheral blood plasma from four multiple myeloma patients. The plasma Y4RNAfr level was abnormal in all four myeloma patients, and the levels for two patients were far beyond the normal level. The WBC for each patient was normal and the CRP levels for two patients were normal. These observations together suggest that a high level of Y4RNAfr in peripheral blood plasma and a normal WBC could be indicative of multiple myeloma. KeAi Publishing 2019-12-17 /pmc/articles/PMC7078377/ /pubmed/32206739 http://dx.doi.org/10.1016/j.ncrna.2019.12.001 Text en © 2020 Production and hosting by Elsevier B.V. on behalf of KeAi Communications Co., Ltd. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Article Ishikawa, Tatsuya Haino, Arisa Seki, Mineaki Kurihara, Taro Hirose, Takayuki Imai, Yosuke Ishiguro, Takuro Chou, Takaaki Toshima, Muneatsu Terada, Hiroshi Nashimoto, Masayuki The 31-nucleotide Y4-RNA fragment in plasma is a potential novel biomarker |
title | The 31-nucleotide Y4-RNA fragment in plasma is a potential novel biomarker |
title_full | The 31-nucleotide Y4-RNA fragment in plasma is a potential novel biomarker |
title_fullStr | The 31-nucleotide Y4-RNA fragment in plasma is a potential novel biomarker |
title_full_unstemmed | The 31-nucleotide Y4-RNA fragment in plasma is a potential novel biomarker |
title_short | The 31-nucleotide Y4-RNA fragment in plasma is a potential novel biomarker |
title_sort | 31-nucleotide y4-rna fragment in plasma is a potential novel biomarker |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7078377/ https://www.ncbi.nlm.nih.gov/pubmed/32206739 http://dx.doi.org/10.1016/j.ncrna.2019.12.001 |
work_keys_str_mv | AT ishikawatatsuya the31nucleotidey4rnafragmentinplasmaisapotentialnovelbiomarker AT hainoarisa the31nucleotidey4rnafragmentinplasmaisapotentialnovelbiomarker AT sekimineaki the31nucleotidey4rnafragmentinplasmaisapotentialnovelbiomarker AT kuriharataro the31nucleotidey4rnafragmentinplasmaisapotentialnovelbiomarker AT hirosetakayuki the31nucleotidey4rnafragmentinplasmaisapotentialnovelbiomarker AT imaiyosuke the31nucleotidey4rnafragmentinplasmaisapotentialnovelbiomarker AT ishigurotakuro the31nucleotidey4rnafragmentinplasmaisapotentialnovelbiomarker AT choutakaaki the31nucleotidey4rnafragmentinplasmaisapotentialnovelbiomarker AT toshimamuneatsu the31nucleotidey4rnafragmentinplasmaisapotentialnovelbiomarker AT teradahiroshi the31nucleotidey4rnafragmentinplasmaisapotentialnovelbiomarker AT nashimotomasayuki the31nucleotidey4rnafragmentinplasmaisapotentialnovelbiomarker AT ishikawatatsuya 31nucleotidey4rnafragmentinplasmaisapotentialnovelbiomarker AT hainoarisa 31nucleotidey4rnafragmentinplasmaisapotentialnovelbiomarker AT sekimineaki 31nucleotidey4rnafragmentinplasmaisapotentialnovelbiomarker AT kuriharataro 31nucleotidey4rnafragmentinplasmaisapotentialnovelbiomarker AT hirosetakayuki 31nucleotidey4rnafragmentinplasmaisapotentialnovelbiomarker AT imaiyosuke 31nucleotidey4rnafragmentinplasmaisapotentialnovelbiomarker AT ishigurotakuro 31nucleotidey4rnafragmentinplasmaisapotentialnovelbiomarker AT choutakaaki 31nucleotidey4rnafragmentinplasmaisapotentialnovelbiomarker AT toshimamuneatsu 31nucleotidey4rnafragmentinplasmaisapotentialnovelbiomarker AT teradahiroshi 31nucleotidey4rnafragmentinplasmaisapotentialnovelbiomarker AT nashimotomasayuki 31nucleotidey4rnafragmentinplasmaisapotentialnovelbiomarker |